CA Stock MarketDetailed Quotes

RX Biosyent Inc

Watchlist
  • 11.300
  • +0.100+0.89%
15min DelayMarket Closed Nov 5 16:00 ET
130.94MMarket Cap18.90P/E (TTM)

Biosyent Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
12.33%8.94M
19.30%7.73M
13.12%31.59M
10.88%8.27M
30.63%8.87M
20.01%7.96M
-7.88%6.48M
-2.42%27.93M
3.37%7.46M
1.50%6.79M
Operating revenue
12.33%8.94M
19.30%7.73M
13.12%31.59M
10.88%8.27M
30.63%8.87M
20.01%7.96M
-7.88%6.48M
-2.42%27.93M
3.37%7.46M
1.50%6.79M
Cost of revenue
27.80%1.87M
38.49%1.59M
18.26%5.99M
23.72%1.57M
53.11%1.81M
25.23%1.47M
-20.65%1.15M
-15.27%5.07M
-9.21%1.27M
-17.56%1.18M
Gross profit
8.84%7.07M
15.17%6.14M
11.99%25.6M
8.25%6.7M
25.90%7.06M
18.90%6.5M
-4.58%5.33M
0.97%22.86M
6.39%6.19M
6.70%5.61M
Operating expense
9.02%5.12M
4.40%4.05M
13.24%18.06M
8.16%5.19M
13.01%4.29M
20.01%4.69M
12.91%3.88M
10.85%15.95M
40.79%4.8M
19.92%3.8M
Selling and administrative expenses
9.96%4.92M
4.04%3.85M
13.36%17.27M
9.56%4.93M
13.40%4.16M
19.01%4.48M
12.07%3.7M
11.53%15.23M
40.41%4.5M
23.61%3.66M
-Selling and marketing expense
17.36%2.15M
-28.09%1.07M
17.77%7.56M
20.88%2.6M
5.09%1.64M
41.22%1.83M
5.49%1.49M
6.35%6.42M
79.23%2.15M
31.85%1.56M
-General and administrative expense
4.83%2.77M
25.68%2.78M
10.15%9.7M
-0.78%2.34M
19.56%2.51M
7.31%2.64M
16.99%2.21M
15.64%8.81M
17.22%2.35M
18.13%2.1M
Research and development costs
--27.67K
134.20%88.21K
-31.20%83.27K
-14.87%41.54K
29.03%20.13K
--0
120.91%37.67K
-24.68%121.03K
9.64%48.8K
-81.94%15.6K
Depreciation amortization depletion
9.11%121.8K
4.14%114.99K
0.96%455.34K
-21.89%121.35K
14.79%111.94K
13.65%111.63K
10.54%110.42K
-1.34%451K
41.38%155.37K
-6.50%97.52K
-Depreciation and amortization
9.11%121.8K
4.14%114.99K
0.96%455.34K
-21.89%121.35K
14.79%111.94K
13.65%111.63K
10.54%110.42K
-1.34%451K
41.38%155.37K
-6.50%97.52K
Provision for doubtful accounts
--0
--0
180.81%140.32K
-23.86%38.05K
--0
--68.45K
--33.82K
--49.97K
--49.97K
--0
Other operating expenses
21.92%45.57K
----
20.99%117.93K
33.40%57.32K
-68.15%7.17K
205.79%37.38K
----
-15.87%97.47K
-10.40%42.97K
65.87%22.51K
Operating profit
8.36%1.95M
43.96%2.09M
9.08%7.53M
8.56%1.51M
52.95%2.77M
16.09%1.8M
-32.52%1.45M
-16.26%6.91M
-42.24%1.39M
-13.36%1.81M
Net non-operating interest income (expenses)
-17.01%223.78K
64.57%317.23K
136.87%1.06M
36.09%325.79K
114.81%274.52K
358.81%269.65K
749.15%192.76K
766.11%448.65K
1,284.85%239.39K
1,154.63%127.8K
Non-operating interest income
-16.79%238.79K
58.14%332.82K
115.13%1.13M
32.61%342.18K
98.30%291.49K
266.65%286.99K
395.29%210.47K
283.66%525.8K
578.53%258.04K
367.62%146.99K
Non-operating interest expense
-13.46%15.01K
-11.95%15.59K
-11.32%68.41K
-12.11%16.39K
-11.62%16.97K
-11.07%17.34K
-10.53%17.71K
-9.51%77.14K
-10.08%18.65K
-9.66%19.2K
Other net income (expenses)
50.97%-26.29K
96.68%-1.53K
-183.97%-63.11K
-15.44%16.56K
-52.28%20.04K
-240.33%-53.63K
-87.13%-46.08K
-4.85%75.16K
-83.33%19.58K
-58.41%41.99K
Gain on sale of security
50.97%-26.29K
96.68%-1.53K
-183.97%-63.11K
-15.44%16.56K
-52.28%20.04K
-240.33%-53.63K
-87.13%-46.08K
263.35%75.16K
358.72%19.58K
-58.41%41.99K
Income before tax
6.55%2.15M
50.50%2.41M
14.85%8.53M
12.27%1.85M
54.71%3.06M
22.36%2.02M
-25.64%1.6M
-11.31%7.43M
-35.13%1.65M
-10.02%1.98M
Income tax
6.55%569.77K
50.50%637.7K
5.14%2.07M
-10.74%403.95K
35.16%711.3K
24.00%534.76K
-24.64%423.73K
-5.94%1.97M
-32.33%452.53K
10.03%526.25K
Earnings from equity interest net of tax
Net income
6.55%1.58M
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
-15.59%1.45M
Net income continuous operations
6.55%1.58M
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
-15.59%1.45M
Noncontrolling interests
Net income attributable to the company
6.55%1.58M
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
-15.59%1.45M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
6.55%1.58M
50.50%1.77M
18.35%6.46M
20.95%1.45M
61.79%2.35M
21.78%1.48M
-25.99%1.18M
-13.11%5.46M
-36.12%1.2M
-15.59%1.45M
Diluted earnings per share
10.57%0.136
56.70%0.152
21.85%0.541
24.00%0.124
67.23%0.199
25.51%0.123
-23.62%0.097
-10.30%0.444
-32.89%0.1
-12.50%0.119
Basic earnings per share
10.74%0.134
56.84%0.149
22.07%0.531
24.74%0.121
68.10%0.195
26.04%0.121
-24.00%0.095
-10.86%0.435
-34.01%0.097
-13.43%0.116
Dividend per share
12.50%0.045
12.50%0.045
300.00%0.16
0.00%0.04
0.04
0.04
0.04
0.04
0.04
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 12.33%8.94M19.30%7.73M13.12%31.59M10.88%8.27M30.63%8.87M20.01%7.96M-7.88%6.48M-2.42%27.93M3.37%7.46M1.50%6.79M
Operating revenue 12.33%8.94M19.30%7.73M13.12%31.59M10.88%8.27M30.63%8.87M20.01%7.96M-7.88%6.48M-2.42%27.93M3.37%7.46M1.50%6.79M
Cost of revenue 27.80%1.87M38.49%1.59M18.26%5.99M23.72%1.57M53.11%1.81M25.23%1.47M-20.65%1.15M-15.27%5.07M-9.21%1.27M-17.56%1.18M
Gross profit 8.84%7.07M15.17%6.14M11.99%25.6M8.25%6.7M25.90%7.06M18.90%6.5M-4.58%5.33M0.97%22.86M6.39%6.19M6.70%5.61M
Operating expense 9.02%5.12M4.40%4.05M13.24%18.06M8.16%5.19M13.01%4.29M20.01%4.69M12.91%3.88M10.85%15.95M40.79%4.8M19.92%3.8M
Selling and administrative expenses 9.96%4.92M4.04%3.85M13.36%17.27M9.56%4.93M13.40%4.16M19.01%4.48M12.07%3.7M11.53%15.23M40.41%4.5M23.61%3.66M
-Selling and marketing expense 17.36%2.15M-28.09%1.07M17.77%7.56M20.88%2.6M5.09%1.64M41.22%1.83M5.49%1.49M6.35%6.42M79.23%2.15M31.85%1.56M
-General and administrative expense 4.83%2.77M25.68%2.78M10.15%9.7M-0.78%2.34M19.56%2.51M7.31%2.64M16.99%2.21M15.64%8.81M17.22%2.35M18.13%2.1M
Research and development costs --27.67K134.20%88.21K-31.20%83.27K-14.87%41.54K29.03%20.13K--0120.91%37.67K-24.68%121.03K9.64%48.8K-81.94%15.6K
Depreciation amortization depletion 9.11%121.8K4.14%114.99K0.96%455.34K-21.89%121.35K14.79%111.94K13.65%111.63K10.54%110.42K-1.34%451K41.38%155.37K-6.50%97.52K
-Depreciation and amortization 9.11%121.8K4.14%114.99K0.96%455.34K-21.89%121.35K14.79%111.94K13.65%111.63K10.54%110.42K-1.34%451K41.38%155.37K-6.50%97.52K
Provision for doubtful accounts --0--0180.81%140.32K-23.86%38.05K--0--68.45K--33.82K--49.97K--49.97K--0
Other operating expenses 21.92%45.57K----20.99%117.93K33.40%57.32K-68.15%7.17K205.79%37.38K-----15.87%97.47K-10.40%42.97K65.87%22.51K
Operating profit 8.36%1.95M43.96%2.09M9.08%7.53M8.56%1.51M52.95%2.77M16.09%1.8M-32.52%1.45M-16.26%6.91M-42.24%1.39M-13.36%1.81M
Net non-operating interest income (expenses) -17.01%223.78K64.57%317.23K136.87%1.06M36.09%325.79K114.81%274.52K358.81%269.65K749.15%192.76K766.11%448.65K1,284.85%239.39K1,154.63%127.8K
Non-operating interest income -16.79%238.79K58.14%332.82K115.13%1.13M32.61%342.18K98.30%291.49K266.65%286.99K395.29%210.47K283.66%525.8K578.53%258.04K367.62%146.99K
Non-operating interest expense -13.46%15.01K-11.95%15.59K-11.32%68.41K-12.11%16.39K-11.62%16.97K-11.07%17.34K-10.53%17.71K-9.51%77.14K-10.08%18.65K-9.66%19.2K
Other net income (expenses) 50.97%-26.29K96.68%-1.53K-183.97%-63.11K-15.44%16.56K-52.28%20.04K-240.33%-53.63K-87.13%-46.08K-4.85%75.16K-83.33%19.58K-58.41%41.99K
Gain on sale of security 50.97%-26.29K96.68%-1.53K-183.97%-63.11K-15.44%16.56K-52.28%20.04K-240.33%-53.63K-87.13%-46.08K263.35%75.16K358.72%19.58K-58.41%41.99K
Income before tax 6.55%2.15M50.50%2.41M14.85%8.53M12.27%1.85M54.71%3.06M22.36%2.02M-25.64%1.6M-11.31%7.43M-35.13%1.65M-10.02%1.98M
Income tax 6.55%569.77K50.50%637.7K5.14%2.07M-10.74%403.95K35.16%711.3K24.00%534.76K-24.64%423.73K-5.94%1.97M-32.33%452.53K10.03%526.25K
Earnings from equity interest net of tax
Net income 6.55%1.58M50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M-15.59%1.45M
Net income continuous operations 6.55%1.58M50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M-15.59%1.45M
Noncontrolling interests
Net income attributable to the company 6.55%1.58M50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M-15.59%1.45M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 6.55%1.58M50.50%1.77M18.35%6.46M20.95%1.45M61.79%2.35M21.78%1.48M-25.99%1.18M-13.11%5.46M-36.12%1.2M-15.59%1.45M
Diluted earnings per share 10.57%0.13656.70%0.15221.85%0.54124.00%0.12467.23%0.19925.51%0.123-23.62%0.097-10.30%0.444-32.89%0.1-12.50%0.119
Basic earnings per share 10.74%0.13456.84%0.14922.07%0.53124.74%0.12168.10%0.19526.04%0.121-24.00%0.095-10.86%0.435-34.01%0.097-13.43%0.116
Dividend per share 12.50%0.04512.50%0.045300.00%0.160.00%0.040.040.040.040.040.04
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data